LLAI vs. LLA, IDHC, DXRX, AGL, YGEN, ABDX, PRM, GDR, VRCI, and GENI
Should you be buying LungLife AI stock or one of its competitors? The main competitors of LungLife AI include LLA.L,0P0001T9GN,0 (LLA), Integrated Diagnostics (IDHC), Diaceutics (DXRX), ANGLE (AGL), Yourgene Health (YGEN), Abingdon Health (ABDX), Proteome Sciences (PRM), genedrive (GDR), Verici Dx (VRCI), and GENinCode (GENI). These companies are all part of the "diagnostics & research" industry.
LungLife AI vs.
LungLife AI (LON:LLAI) and LLA.L,0P0001T9GN,0 (LON:LLA) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, dividends, community ranking, earnings, risk, valuation and profitability.
LungLife AI has a beta of -0.3, suggesting that its stock price is 130% less volatile than the S&P 500. Comparatively, LLA.L,0P0001T9GN,0 has a beta of -0.3, suggesting that its stock price is 130% less volatile than the S&P 500.
LLA.L,0P0001T9GN,0 has a net margin of 0.00% compared to LungLife AI's net margin of -15,403.45%. LLA.L,0P0001T9GN,0's return on equity of -48.59% beat LungLife AI's return on equity.
LungLife AI and LLA.L,0P0001T9GN,0 both received 0 outperform votes by MarketBeat users.
LLA.L,0P0001T9GN,0 has lower revenue, but higher earnings than LungLife AI. LungLife AI is trading at a lower price-to-earnings ratio than LLA.L,0P0001T9GN,0, indicating that it is currently the more affordable of the two stocks.
In the previous week, LungLife AI's average media sentiment score of 0.00 equaled LLA.L,0P0001T9GN,0'saverage media sentiment score.
42.5% of LungLife AI shares are held by institutional investors. Comparatively, 5.4% of LLA.L,0P0001T9GN,0 shares are held by institutional investors. 48.4% of LungLife AI shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.
Summary
LungLife AI and LLA.L,0P0001T9GN,0 tied by winning 4 of the 8 factors compared between the two stocks.
Get LungLife AI News Delivered to You Automatically
Sign up to receive the latest news and ratings for LLAI and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
LungLife AI Competitors List
Related Companies and Tools
This page (LON:LLAI) was last updated on 4/8/2025 by MarketBeat.com Staff
Buy LLAI Stock Free LLAI Stock Alerts